SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Miromatrix Medical Inc. (MIRO) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+165.5%).
- Analyst consensus target $9.00 (+165.5% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 54/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MIRO
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio73.70
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.45
Book Value / Share$0.00
Revenue / Share$0.05
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$9.00 (+165.5%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.29 |
$250K |
$-3.07M |
-1228.1% |
| 2020 |
$-0.82 |
$46.53K |
$-8.72M |
-18732.7% |
| 2021 |
$-1.30 |
$33.07K |
$-14.96M |
-45230% |
| 2022 |
$-1.45 |
$953.47K |
$-30.01M |
-3147.2% |
